Study S001536

Effect of Short-term Intensive Insulin Sequential Exenatide Therapy on Beta Cell Function and Glycaemic Control in Patients With Newly Diagnosed Type 2 Diabetes :a Multicenter Prospective Randomized Control Study

ClinicalTrials.gov record

Registration

Registration: NCT02129985
Acronym: T2DMRS
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 100
Start: 2014-02
Primary completion: 2015-06
Lead sponsor: xiaolong zhao
Conditions: Type 2 Diabetes
Interventions: DRUG:Exenatide; DRUG:Metformin
Results posted: FALSE

Registered primary outcomes

time to glycaemic remission [up to 1 year]
remission rate of type 2 diabetes at a year. [up to 1 year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.